Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Saskatchewan

$43,000.00

Synthesis and physicochemical study of new chemical tools towards ideal radiometal- and peptide-based constructs

EF 2024-25

Résumé
Price Research Group @USask. My chemistry research program synthesizes, studies, and optimizes modular chemical tools such as chelators and linkers (e.g. unnatural amino acids), which are critical building blocks for the construction of new radiolabeled molecules. My chemistry program primarily trains chemists and radiochemists, while also sustaining many collaborations and interfacing between chemistry, radiochemistry, and nuclear medicine. We have filed patents on some of our new chemical tools, and recently spun out a startup company for radiochemistry supplies called General Science Inventions Inc. My trainees time is ~75% spent doing multi-step chemical synthesis, ~20% radiochemistry, and ~5% working with collaborators to complete basic assays in cells or healthy mice to assess how the in vitro physicochemical properties of our new chemical tools translate to in vivo changes in pharmacokinetics, stability, or other properties of radiolabeled molecules. Seeing the radiochemistry applications has helped motivate my trainees for the long and challenging syntheses required beforehand. If one of our new chemical tools such as zirconium-89 chelators looks promising after synthesis and physicochemical/radiochemical evaluation, we then collaborate with experts in disease models and apply for health focused funding such as CIHR. 1) The first main direction in my chemistry research program involves the design and synthesis of a modular bifunctional chelate platform for radiometals. This proposal aims to take our previously published and modular chelate platform and improve it through three directions. oObjective 1A) Incorporate zwitterionic (ZW) moieties into chelators to improve solubility and conjugation efficiency and probe effects on chelation. oObjective 1B) Synthesize and study new crown ether-based macrocyclic chelators based on "macropa" for actinium-225 chelation. oObjective 1C) Combine our DFO-Km or DFO2K chelators for zirconium-89 imaging (1A) with new chelators for actinium-225 therapy (1B) into a single dual-radiometal platform. 2) The second main direction involves the design, synthesis, and physicochemical characterization of a family of un-natural amino acids, and to use radiochemistry to evaluate their properties in biological systems. These unnatural ZW amino acids have been pioneered by my lab for the last ~6 years and they have been shown to add "biological non-stick" properties to peptides and act as potent pharmacokinetic modulators, with other promising applications to chelators, antibodies, and nanoparticles. oObjective 2A) Synthesize a small library of amino acids bearing "permanent" ZW moieties, study their physicochemical properties, and chemically incorporate them into various types of molecules to gain "non-stick". oObjective 2B) Synthesize amino acids bearing blood albumin-binding moieties to increase blood half-life and tumour-uptake of peptide-based radiotracers.
Programme
Discovery Grants Program - Individual
Emplacement
Saskatchewan, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2024-06071
Name nom
Price, Eric
Department département
Chemistry
Organization id
16
Institution établissement
University of Saskatchewan
Province en
Saskatchewan
Province fr
Saskatchewan
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
43000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3603
Research subject group en
Inorganic chemistry
Research subject group fr
Chimie inorganique
Research subject en
Bio-inorganic chemistry
Research subject fr
Chimie bio-inorganique
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Synthesis and physicochemical study of new chemical tools towards ideal radiometal- and peptide-based constructs
Keywords
chelators; peptides; zwitterions; unnatural amino acids; radiopharmaceuticals; theranostics; organic synthesis; bioconjugation; coordination chemistry; radiochemistry
Application summary
Price Research Group @USask. My chemistry research program synthesizes, studies, and optimizes modular chemical tools such as chelators and linkers (e.g. unnatural amino acids), which are critical building blocks for the construction of new radiolabeled molecules. My chemistry program primarily trains chemists and radiochemists, while also sustaining many collaborations and interfacing between chemistry, radiochemistry, and nuclear medicine. We have filed patents on some of our new chemical tools, and recently spun out a startup company for radiochemistry supplies called General Science Inventions Inc. My trainees time is ~75% spent doing multi-step chemical synthesis, ~20% radiochemistry, and ~5% working with collaborators to complete basic assays in cells or healthy mice to assess how the in vitro physicochemical properties of our new chemical tools translate to in vivo changes in pharmacokinetics, stability, or other properties of radiolabeled molecules. Seeing the radiochemistry applications has helped motivate my trainees for the long and challenging syntheses required beforehand. If one of our new chemical tools such as zirconium-89 chelators looks promising after synthesis and physicochemical/radiochemical evaluation, we then collaborate with experts in disease models and apply for health focused funding such as CIHR. 1) The first main direction in my chemistry research program involves the design and synthesis of a modular bifunctional chelate platform for radiometals. This proposal aims to take our previously published and modular chelate platform and improve it through three directions. oObjective 1A) Incorporate zwitterionic (ZW) moieties into chelators to improve solubility and conjugation efficiency and probe effects on chelation. oObjective 1B) Synthesize and study new crown ether-based macrocyclic chelators based on "macropa" for actinium-225 chelation. oObjective 1C) Combine our DFO-Km or DFO2K chelators for zirconium-89 imaging (1A) with new chelators for actinium-225 therapy (1B) into a single dual-radiometal platform. 2) The second main direction involves the design, synthesis, and physicochemical characterization of a family of un-natural amino acids, and to use radiochemistry to evaluate their properties in biological systems. These unnatural ZW amino acids have been pioneered by my lab for the last ~6 years and they have been shown to add "biological non-stick" properties to peptides and act as potent pharmacokinetic modulators, with other promising applications to chelators, antibodies, and nanoparticles. oObjective 2A) Synthesize a small library of amino acids bearing "permanent" ZW moieties, study their physicochemical properties, and chemically incorporate them into various types of molecules to gain "non-stick". oObjective 2B) Synthesize amino acids bearing blood albumin-binding moieties to increase blood half-life and tumour-uptake of peptide-based radiotracers.